Business Practice

Experts suggest that outsourcing CGT manufacturing capabilities to CDMOs brings additional benefits, although not without challenges

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Is renting material handling equipment the best way to help manufacturers tackle waste?

Experts discuss the most promising growth prospects in the cell and gene landscape

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

Transporting temperature-sensitive pharmaceuticals is only going to become more challenging as we face the realities of the climate crisis.

How to ensure your reaction to recalls is driven by data and knowledge.

Watch our roundtable discussion featuring experts from Terumo Blood and Cell Technologies, Orgenesis, ScaleReady, and BioBridge Global

Humira biosimilars finally launch on the US market